BEND THE CARRYING CURVE Trademark

Trademark Overview


On Tuesday, February 13, 2024, a trademark application was filed for BEND THE CARRYING CURVE with the United States Patent and Trademark Office. The USPTO has given the BEND THE CARRYING CURVE trademark a serial number of 98404634. The federal status of this trademark filing is NEW APPLICATION - ASSIGNED TO EXAMINER as of Saturday, June 29, 2024. This trademark is owned by Aquestive Therapeutics, Inc.. The BEND THE CARRYING CURVE trademark is filed in the Pharmaceutical Products category with the following description:

Films dissolvable in the mouth for the oral delivery of drugs, pharmaceuticals to humans; Dissolvable polymer films as a base in preparations for oral, sublingual, buccal, or transmucosal delivery of pharmaceutically active ingredients; Drug delivery platform technology, namely, drug delivery agents consisting of compounds that facilitate, enhance or promote optimized delivery, dosing management and accuracy, enhanced solubility, enhanced permeability, or enhanced absorption of a wide range of pharmaceutical agents; pharmaceutical preparations, namely, oral, sublingual, buccal, topical or transmucosal delivery enhancement agents to facilitate, enhance, or promote optimized delivery, efficacy, dosing management and accuracy, enhanced solubility, enhanced permeability or enhanced absorption of a variety of pharmaceutical agents
bend the carrying curve

General Information


Serial Number98404634
Word MarkBEND THE CARRYING CURVE
Filing DateTuesday, February 13, 2024
Status638 - NEW APPLICATION - ASSIGNED TO EXAMINER
Status DateSaturday, June 29, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesFilms dissolvable in the mouth for the oral delivery of drugs, pharmaceuticals to humans; Dissolvable polymer films as a base in preparations for oral, sublingual, buccal, or transmucosal delivery of pharmaceutically active ingredients; Drug delivery platform technology, namely, drug delivery agents consisting of compounds that facilitate, enhance or promote optimized delivery, dosing management and accuracy, enhanced solubility, enhanced permeability, or enhanced absorption of a wide range of pharmaceutical agents; pharmaceutical preparations, namely, oral, sublingual, buccal, topical or transmucosal delivery enhancement agents to facilitate, enhance, or promote optimized delivery, efficacy, dosing management and accuracy, enhanced solubility, enhanced permeability or enhanced absorption of a variety of pharmaceutical agents

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, February 13, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAquestive Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWarren, NJ 07059

Trademark Events


Event DateEvent Description
Wednesday, February 14, 2024NEW APPLICATION ENTERED
Sunday, June 16, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, June 29, 2024ASSIGNED TO EXAMINER